Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 899

1.

Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model.

Deken MM, Bos DL, Tummers WSFJ, March TL, van de Velde CJH, Rijpkema M, Vahrmeijer AL.

EJNMMI Res. 2019 Nov 21;9(1):98. doi: 10.1186/s13550-019-0564-z.

PMID:
31754913
2.

Estrogen Receptor pathway activity score to predict clinical response or resistance to neo-adjuvant endocrine therapy in primary breast cancer.

Inda MA, Blok EJ, Kuppen PJK, Charehbili A, den Biezen-Timmermans EC, van Brussel A, Fruytier SE, Meershoek-Klein Kranenbarg E, Kloet SL, van der Burg B, Martens JWM, Sims AH, Turnbull AK, Dixon JM, Verhaegh W, Kroep JR, van de Velde CJH, van de Stolpe A.

Mol Cancer Ther. 2019 Nov 14. pii: molcanther.0318.2019. doi: 10.1158/1535-7163.MCT-19-0318. [Epub ahead of print]

PMID:
31727690
3.

Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommnendation to optimize the performance.

Simons JM, Maaskant-Braat AJG, Luiten EJT, Leidenius MH, van Nijnatten TJA, Boelens PG, Koppert LB, van der Pol CC, van de Velde CJH, Audisio RA, Smidt ML.

Eur J Surg Oncol. 2019 Oct 22. pii: S0748-7983(19)30902-3. doi: 10.1016/j.ejso.2019.10.022. [Epub ahead of print] No abstract available.

PMID:
31662226
4.

Multicentre study of surgical referral and outcomes of patients with benign colorectal lesions.

Vermeer NCA, de Neree Tot Babberich MPM, Fockens P, Nagtegaal ID, van de Velde CJH, Dekker E, Tanis PJ, Peeters KCMJ.

BJS Open. 2019 Jul 30;3(5):687-695. doi: 10.1002/bjs5.50181. eCollection 2019 Oct.

5.

Cluster-randomized crossover trial of chlorhexidine-alcohol versus iodine-alcohol for prevention of surgical-site infection (SKINFECT trial).

Charehbili A, Koek MBG, de Mol van Otterloo JCA, Bronkhorst MWGA, van der Zwaal P, Thomassen B, Waasdorp EJ, Govaert JA, Bosman A, van den Bremer J, Ploeg AJ, Putter H, Meijs AP, van de Velde CJH, van Gijn W, Swijnenburg RJ.

BJS Open. 2019 May 20;3(5):617-622. doi: 10.1002/bjs5.50177. eCollection 2019 Oct.

6.

Patterns of axillary staging and management in clinically node positive breast cancer patients treated with neoadjuvant systemic therapy: Results of a survey amongst breast cancer specialists.

Simons JM, Maaskant-Braat AJG, Luiten EJT, Leidenius MHK, van Nijnatten TJA, Boelens PG, Koppert LB, van der Pol CC, van de Velde CJH, Audisio RA, Smidt ML.

Eur J Surg Oncol. 2019 Aug 13. pii: S0748-7983(19)30627-4. doi: 10.1016/j.ejso.2019.08.012. [Epub ahead of print]

PMID:
31434617
7.

Quantitative margin assessment of radiofrequency ablation of a solitary colorectal hepatic metastasis using MIRADA RTx on CT scans: a feasibility study.

Sibinga Mulder BG, Hendriks P, Baetens TR, van Erkel AR, van Rijswijk CSP, van der Meer RW, van de Velde CJH, Vahrmeijer AL, Mieog JSD, Burgmans MC.

BMC Med Imaging. 2019 Aug 20;19(1):71. doi: 10.1186/s12880-019-0360-2.

8.

The role of the longitudinal muscle in the anal sphincter complex: Implications for the Intersphincteric Plane in Low Rectal Cancer Surgery?

Kraima AC, West NP, Roberts N, Magee DR, Smit NN, van de Velde CJH, DeRuiter MC, Rutten HJ, Quirke P.

Clin Anat. 2019 Aug 5. doi: 10.1002/ca.23444. [Epub ahead of print]

PMID:
31385374
9.

Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.

Ogura A, Konishi T, Beets GL, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K, Lee P, Putter H, van de Velde CJH, Rutten HJT, Tuynman JB, Kusters M; Lateral Node Study Consortium.

JAMA Surg. 2019 Jul 3:e192172. doi: 10.1001/jamasurg.2019.2172. [Epub ahead of print]

PMID:
31268504
10.

Extending the hybrid surgical guidance concept with freehand fluorescence tomography.

van Oosterom MN, Meershoek P, Welling MM, Pinto F, Matthies P, Simon H, Wendler T, Navab N, van de Velde CJH, van der Poel HG, van Leeuwen FWB.

IEEE Trans Med Imaging. 2019 Jun 21. doi: 10.1109/TMI.2019.2924254. [Epub ahead of print]

PMID:
31247546
11.

Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.

Detering R, Karthaus EG, Borstlap WAA, Marijnen CAM, van de Velde CJH, Bemelman WA, Beets GL, Tanis PJ, Aalbers AGJ; Dutch Snapshot Research Group.

Eur J Surg Oncol. 2019 Nov;45(11):2059-2069. doi: 10.1016/j.ejso.2019.06.016. Epub 2019 Jun 17.

PMID:
31230980
12.

Genome-wide cell-free DNA fragmentation in patients with cancer.

Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, Jensen SØ, Medina JE, Hruban C, White JR, Palsgrove DN, Niknafs N, Anagnostou V, Forde P, Naidoo J, Marrone K, Brahmer J, Woodward BD, Husain H, van Rooijen KL, Ørntoft MW, Madsen AH, van de Velde CJH, Verheij M, Cats A, Punt CJA, Vink GR, van Grieken NCT, Koopman M, Fijneman RJA, Johansen JS, Nielsen HJ, Meijer GA, Andersen CL, Scharpf RB, Velculescu VE.

Nature. 2019 Jun;570(7761):385-389. doi: 10.1038/s41586-019-1272-6. Epub 2019 May 29.

13.

A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer.

Krijgsman D, Van Vlierberghe RLP, Evangelou V, Vahrmeijer AL, Van de Velde CJH, Sier CFM, Kuppen PJK.

Eur J Histochem. 2019 May 20;63(2). doi: 10.4081/ejh.2019.3028.

14.

Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.

Krijgsman D, de Vries NL, Skovbo A, Andersen MN, Swets M, Bastiaannet E, Vahrmeijer AL, van de Velde CJH, Heemskerk MHM, Hokland M, Kuppen PJK.

Cancer Immunol Immunother. 2019 Jun;68(6):1011-1024. doi: 10.1007/s00262-019-02343-7. Epub 2019 May 3.

15.

Time trends of short-term mortality for octogenarians undergoing a colorectal resection in North Europe.

Claassen YHM, Bastiaannet E, van Eycken E, Van Damme N, Martling A, Johansson R, Iversen LH, Ingeholm P, Lemmens VEPP, Liefers GJ, Holman FA, Dekker JWT, Portielje JEA, Rutten HJ, van de Velde CJH.

Eur J Surg Oncol. 2019 Aug;45(8):1396-1402. doi: 10.1016/j.ejso.2019.03.041. Epub 2019 Apr 9.

PMID:
31003722
16.

National cohort study on postoperative risks after surgery for submucosal invasive colorectal cancer.

Vermeer NCA, Backes Y, Snijders HS, Bastiaannet E, Liefers GJ, Moons LMG, van de Velde CJH, Peeters KCMJ; Dutch T1 Colorectal Cancer Working Group.

BJS Open. 2018 Dec 24;3(2):210-217. doi: 10.1002/bjs5.50125. eCollection 2019 Apr.

17.

Impact of resection margin status on recurrence and survival in pancreatic cancer surgery.

Tummers WS, Groen JV, Sibinga Mulder BG, Farina-Sarasqueta A, Morreau J, Putter H, van de Velde CJ, Vahrmeijer AL, Bonsing BA, Mieog JS, Swijnenburg RJ.

Br J Surg. 2019 Jul;106(8):1055-1065. doi: 10.1002/bjs.11115. Epub 2019 Mar 18.

18.

Quality of Life After Curative Resection for Rectal Cancer in Patients Treated With Adjuvant Chemotherapy Compared With Observation: Results of the Randomized Phase III SCRIPT Trial.

van der Valk MJM, Hilling DE, Meershoek-Klein Kranenbarg E, Peeters KCMJ, Kapiteijn E, Tsonaka R, van de Velde CJH, Marang-van de Mheen PJ.

Dis Colon Rectum. 2019 Jun;62(6):711-720. doi: 10.1097/DCR.0000000000001336.

PMID:
30870225
19.

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.

de Groot AF, Blok EJ, Charehbili A, Engels CC, Smit VTHBM, Dekker-Ensink NG, Putter H, Meershoek-Klein Kranenbarg E, van de Velde CJH, Liefers GJ, Nortier JWR, Kuppen PJK, van der Burg SH, Kroep JR.

Breast Cancer Res Treat. 2019 Jun;175(3):605-615. doi: 10.1007/s10549-019-05195-y. Epub 2019 Mar 13.

20.

Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation.

Boogerd LSF, Boonstra MC, Prevoo HAJM, Handgraaf HJM, Kuppen PJK, van de Velde CJH, Fish A, Cordfunke RA, Valentijn ARPM, Terwisscha van Scheltinga AG, MacDonald GC, Cizeau J, Premsukh A, Vinkenburg van Slooten ML, Burggraaf J, Sier CFM, Vahrmeijer AL.

Surg Oncol. 2019 Mar;28:1-8. doi: 10.1016/j.suronc.2018.10.004. Epub 2018 Oct 23.

PMID:
30851880
21.

Disqualification of Neoadjuvant Rectal Score Based on Data of 6596 Patients From the Netherlands Cancer Registry.

van der Valk MJM, Vuijk FA, Putter H, van de Velde CJH, Beets GL, Hilling DE.

Clin Colorectal Cancer. 2019 Jun;18(2):e231-e236. doi: 10.1016/j.clcc.2019.01.001. Epub 2019 Jan 19.

PMID:
30772135
22.

International benchmarking in oesophageal and gastric cancer surgery.

Busweiler LAD, Jeremiasen M, Wijnhoven BPL, Lindblad M, Lundell L, van de Velde CJH, Tollenaar RAEM, Wouters MWJM, van Sandick JW, Johansson J, Dikken JL.

BJS Open. 2018 Oct 19;3(1):62-73. doi: 10.1002/bjs5.50107. eCollection 2019 Feb.

23.

International comparison of treatment strategy and survival in metastatic gastric cancer.

Claassen YHM, Bastiaannet E, Hartgrink HH, Dikken JL, de Steur WO, Slingerland M, Verhoeven RHA, van Eycken E, de Schutter H, Lindblad M, Hedberg J, Johnson E, Hjortland GO, Jensen LS, Larsson HJ, Koessler T, Chevallay M, Allum WH, van de Velde CJH.

BJS Open. 2018 Oct 9;3(1):56-61. doi: 10.1002/bjs5.103. eCollection 2019 Feb.

24.

Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.

Derks MGM, van de Velde CJH, Giardiello D, Seynaeve C, Putter H, Nortier JWR, Dirix LY, Bastiaannet E, Portielje JEA, Liefers GJ.

Oncologist. 2019 Jul;24(7):e467-e474. doi: 10.1634/theoncologist.2018-0010. Epub 2019 Jan 3.

PMID:
30606886
25.

A dual-labeled cRGD-based PET/optical tracer for pre-operative staging and intraoperative treatment of colorectal cancer.

Sibinga Mulder BG, Handgraaf HJ, Vugts DJ, Sewing C, Windhorst AD, Stammes M, de Geus-Oei LF, Bordo MW, Mieog JSD, van de Velde CJ, Frangioni JV, Vahrmeijer AL.

Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):282-291. eCollection 2018.

26.

Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer.

Claassen YH, van der Valk MJ, Breugom AJ, Frouws MA, Bastiaannet E, Liefers GJ, van de Velde CJ, Kapiteijn E.

Cochrane Database Syst Rev. 2018 Nov 21;11:CD012326. doi: 10.1002/14651858.CD012326.pub2.

27.

Pathway-based subnetworks enable cross-disease biomarker discovery.

Haider S, Yao CQ, Sabine VS, Grzadkowski M, Stimper V, Starmans MHW, Wang J, Nguyen F, Moon NC, Lin X, Drake C, Crozier CA, Brookes CL, van de Velde CJH, Hasenburg A, Kieback DG, Markopoulos CJ, Dirix LY, Seynaeve C, Rea DW, Kasprzyk A, Lambin P, Lio' P, Bartlett JMS, Boutros PC.

Nat Commun. 2018 Nov 12;9(1):4746. doi: 10.1038/s41467-018-07021-3.

28.

Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.

Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K, Lee P, Putter H, van de Velde CJH, Beets GL, Rutten HJT, Kusters M; Lateral Node Study Consortium.

J Clin Oncol. 2019 Jan 1;37(1):33-43. doi: 10.1200/JCO.18.00032. Epub 2018 Nov 7.

29.

North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis.

Claassen YHM, Dikken JL, Hartgrink HH, de Steur WO, Slingerland M, Verhoeven RHA, van Eycken E, de Schutter H, Johansson J, Rouvelas I, Johnson E, Hjortland GO, Jensen LS, Larsson HJ, Allum WH, Portielje JEA, Bastiaannet E, van de Velde CJH.

Eur J Surg Oncol. 2018 Dec;44(12):1982-1989. doi: 10.1016/j.ejso.2018.09.014. Epub 2018 Oct 16.

PMID:
30343998
30.

Decrease in 30-day and one-year mortality over time in patients aged ≥75 years with stage I-III colon cancer: A population-based study.

Breugom AJ, Bastiaannet E, Dekker JWT, Wouters MWJM, van de Velde CJH, Liefers GJ.

Eur J Surg Oncol. 2018 Dec;44(12):1889-1893. doi: 10.1016/j.ejso.2018.08.010. Epub 2018 Aug 29.

PMID:
30262327
31.

Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial.

Claassen YHM, Hartgrink HH, de Steur WO, Dikken JL, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Kranenbarg WMM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH.

Gastric Cancer. 2019 Mar;22(2):369-376. doi: 10.1007/s10120-018-0875-1. Epub 2018 Sep 20.

32.

Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium.

Groen JV, Sibinga Mulder BG, van Eycken E, Valerianova Z, Borras JM, van der Geest LGM, Capretti G, Schlesinger-Raab A, Primic-Zakelj M, Ryzhov A, van de Velde CJH, Bonsing BA, Bastiaannet E, Mieog JSD.

Ann Surg Oncol. 2018 Nov;25(12):3492-3501. doi: 10.1245/s10434-018-6705-1. Epub 2018 Aug 27.

PMID:
30151560
33.

Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison.

Claassen YHM, Vermeer NCA, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Codina Cazador A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Rutten HJT, Portielje JEA, Liefers GJ, Holman FA, van de Velde CJH, Bastiaannet E.

Br J Cancer. 2018 Aug;119(4):517-522. doi: 10.1038/s41416-018-0215-6. Epub 2018 Jul 30.

34.

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent.

Hoogstins CES, Boogerd LSF, Sibinga Mulder BG, Mieog JSD, Swijnenburg RJ, van de Velde CJH, Farina Sarasqueta A, Bonsing BA, Framery B, Pèlegrin A, Gutowski M, Cailler F, Burggraaf J, Vahrmeijer AL.

Ann Surg Oncol. 2018 Oct;25(11):3350-3357. doi: 10.1245/s10434-018-6655-7. Epub 2018 Jul 26.

35.

HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic.

Swets M, Wouters A, Krijgsman D, van Vlierberghe RLP, Boot A, van Eendenburg JD, van Wezel T, Gelderblom H, van de Velde CJH, van den Elsen PJ, Kuppen PJK.

Clin Immunol. 2018 Sep;194:80-86. doi: 10.1016/j.clim.2018.07.005. Epub 2018 Jul 10.

PMID:
30006120
36.

Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results From the CRITICS Trial.

Claassen YHM, van Amelsfoort RM, Hartgrink HH, Dikken JL, de Steur WO, van Sandick JW, van Grieken NCT, Cats A, Boot H, Trip AK, Jansen EPM, Kranenbarg EM, Braak JPBM, Putter H, Henegouwen MIVB, Verheij M, van de Velde CJH.

Ann Surg. 2019 Dec;270(6):1096-1102. doi: 10.1097/SLA.0000000000002940.

PMID:
29995679
37.

Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.

van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJH; IWWD Consortium.

Lancet. 2018 Jun 23;391(10139):2537-2545. doi: 10.1016/S0140-6736(18)31078-X.

PMID:
29976470
38.

Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania.

Breugom AJ, Bastiaannet E, Boelens PG, Van Eycken E, Iversen LH, Martling A, Johansson R, Evans T, Lawton S, O'Brien KM, Ortiz H, Janciauskiene R, Dekkers OM, Rutten HJT, Liefers GJ, Lemmens VEPP, van de Velde CJH.

Eur J Surg Oncol. 2018 Sep;44(9):1338-1343. doi: 10.1016/j.ejso.2018.05.025. Epub 2018 May 26.

PMID:
29960770
39.

Introduction of a colorectal cancer screening programme: results from a single-centre study.

Vermeer NCA, Bahadoer RR, Bastiaannet E, Holman FA, Meershoek-Klein Kranenbarg E, Liefers GJ, van de Velde CJH, Peeters KCMJ.

Colorectal Dis. 2018 Sep;20(9):O239-O247. doi: 10.1111/codi.14313. Epub 2018 Jul 16.

PMID:
29917325
40.

Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial.

Roseweir AK, Bennett L, Dickson A, Cheng K, Quintayo MA, Bayani J, McMillan DC, Horgan PG, van de Velde CJH, Seynaeve C, Hasenburg A, Kieback DG, Markopoulos C, Dirix LY, Rea DW, Mallon EA, Bartlett JMS, Edwards J.

J Natl Cancer Inst. 2018 Jun 1;110(6):616-627. doi: 10.1093/jnci/djx255.

PMID:
29917140
41.

Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial.

Derks MGM, Bastiaannet E, van de Water W, de Glas NA, Seynaeve C, Putter H, Nortier JWR, Rea D, Hasenburg A, Markopoulos C, Dirix LY, Portielje JEA, van de Velde CJH, Liefers GJ.

Eur J Cancer. 2018 Aug;99:1-8. doi: 10.1016/j.ejca.2018.04.009. Epub 2018 Jun 6.

PMID:
29885375
42.

Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group.

Derks MGM, Bastiaannet E, Kiderlen M, Hilling DE, Boelens PG, Walsh PM, van Eycken E, Siesling S, Broggio J, Wyld L, Trojanowski M, Kolacinska A, Chalubinska-Fendler J, Gonçalves AF, Nowikiewicz T, Zegarski W, Audisio RA, Liefers GJ, Portielje JEA, van de Velde CJH; EURECCA Breast Cancer Group.

Br J Cancer. 2018 Jul;119(1):121-129. doi: 10.1038/s41416-018-0090-1. Epub 2018 Jun 7.

43.

Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer.

Blok EJ, Engels CC, Dekker-Ensink G, Meershoek-Klein Kranenbarg E, Putter H, Smit VTHBM, Liefers GJ, Morden JP, Bliss JM, Coombes RC, Bartlett JMS, Kroep JR, van de Velde CJH, Kuppen PJK.

Breast Cancer Res Treat. 2018 Aug;171(1):65-74. doi: 10.1007/s10549-018-4785-z. Epub 2018 May 15.

PMID:
29766362
44.

Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial.

Claassen YHM, van Sandick JW, Hartgrink HH, Dikken JL, De Steur WO, van Grieken NCT, Boot H, Cats A, Trip AK, Jansen EPM, Meershoek-Klein Kranenbarg WM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH.

Br J Surg. 2018 May;105(6):728-735. doi: 10.1002/bjs.10773.

PMID:
29652082
45.

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.

Cats A, Jansen EPM, van Grieken NCT, Sikorska K, Lind P, Nordsmark M, Meershoek-Klein Kranenbarg E, Boot H, Trip AK, Swellengrebel HAM, van Laarhoven HWM, Putter H, van Sandick JW, van Berge Henegouwen MI, Hartgrink HH, van Tinteren H, van de Velde CJH, Verheij M; CRITICS investigators.

Lancet Oncol. 2018 May;19(5):616-628. doi: 10.1016/S1470-2045(18)30132-3. Epub 2018 Apr 9.

PMID:
29650363
46.

Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer.

Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, Liefers GJ, Nortier JWR, Rutgers EJT, Seynaeve CM, van de Velde CJH; IDEAL and TEAM Study Groups.

Eur J Cancer. 2018 May;95:59-67. doi: 10.1016/j.ejca.2018.03.014. Epub 2018 Apr 7.

PMID:
29635145
47.

Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy.

Boogerd LS, van der Valk MJ, Boonstra MC, Prevoo HA, Hilling DE, van de Velde CJ, Sier CF, Fariña Sarasqueta A, Vahrmeijer AL.

Onco Targets Ther. 2018 Mar 23;11:1655-1664. doi: 10.2147/OTT.S145473. eCollection 2018.

48.

Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International Comparison.

Vermeer NCA, Claassen YHM, Derks MGM, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Portielje JEA, Liefers GJ, Peeters KCMJ, van de Velde CJH, Bastiaannet E.

Oncologist. 2018 Aug;23(8):982-990. doi: 10.1634/theoncologist.2017-0551. Epub 2018 Mar 22.

49.

Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial.

Claassen YHM, Hartgrink HH, Dikken JL, de Steur WO, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Meershoek-Klein Kranenbarg WM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH.

Eur J Surg Oncol. 2018 May;44(5):613-619. doi: 10.1016/j.ejso.2018.02.004. Epub 2018 Feb 9.

PMID:
29503129
50.

Quality assurance and sustainability of cancer care: A European network is needed.

Rossi CR, Sommariva A, Bastiaannet E, Van De Velde CJH.

Eur J Surg Oncol. 2018 Apr;44(4):383-385. doi: 10.1016/j.ejso.2017.12.009. Epub 2018 Jan 16. No abstract available.

PMID:
29429596

Supplemental Content

Loading ...
Support Center